XML 69 R57.htm IDEA: XBRL DOCUMENT v3.25.3
SCHEDULE OF BREAKDOWN OF SIGNIFICANT OPERATING EXPENSES (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Revenue $ 487 $ 581  
Cost of revenues (60) 96  
Gross profit 547 485  
Research and development by significant expense:          
Research and development 1,035 1,001 3,480 3,446  
General and administrative by significant expense:          
General and administrative 958 3,381 3,745 11,592  
Gain on lease termination (1,576) (1,576)  
Total operating expenses 1,993 2,806 7,225 13,462  
Loss from operations (1,993) (2,259) (7,225) (12,977)  
Other income (expense), net          
Forward sales contract expense (5,847)  
Gain (loss) on extinguishment of debt 734 (22,440) 734 (22,440)  
Fair value adjustments to bridge notes derivative liability (1,038) (1,038)  
Change in fair value of warrant liabilities 831 1 897  
Change in fair value of contingent consideration 66  
Interest income (expense), net 31 (1,686) 36 (3,269)  
Other expense, net (6) (264)  
Total other income (expense), net 759 (24,333) (5,340) (25,784)  
Loss before income taxes (1,234) (26,592) (12,565) (38,761)  
Provision for income taxes (6) (12) (17) (19)  
Net loss (1,240) (26,604) (12,582) (38,780)  
Cash 3,047   3,047   $ 1,729
MSA/License Fees [Member]          
Research and development by significant expense:          
Research and development 510 767 1,810 2,392  
Study Fees [Member]          
Research and development by significant expense:          
Research and development 60 48 472 200  
Professional Fees [Member]          
Research and development by significant expense:          
Research and development 233 64 591 152  
General and administrative by significant expense:          
General and administrative 215 1,125 1,041 3,409  
Payroll and Related [Member]          
Research and development by significant expense:          
Research and development 123 71 365 518  
General and administrative by significant expense:          
General and administrative 313 367 1,134 1,234  
Other [Member]          
Research and development by significant expense:          
Research and development [1] 109 51 242 184  
General and administrative by significant expense:          
General and administrative [2] 140 230 426 845  
Stock Based Compensation [Member]          
General and administrative by significant expense:          
General and administrative 284 392 1,123 1,036  
Occupancy Expense [Member]          
General and administrative by significant expense:          
General and administrative $ 6 $ 1,267 $ 21 $ 5,068  
[1] Other includes certain lab supply expenses, amounts related to the close out of a former clinical trial, allocated occupancy costs, stock-based compensation, and depreciation.
[2] Other includes expenses related to insurance, information technology, travel, banking, depreciation and other miscellaneous expenses.